Literature DB >> 35718058

Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice.

Nairita Roy1, Frances Alencastro1, Bayley A Roseman1, Sierra R Wilson1, Evan R Delgado1, Meredith C May1, Bharat Bhushan2, Fiona M Bello3, Michael J Jurczak3, Sruti Shiva4, Joseph Locker2, Sebastien Gingras5, Andrew W Duncan6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an epidemic affecting 30% of the US population. It is characterized by insulin resistance, and by defective lipid metabolism and mitochondrial dysfunction in the liver. SLC25A34 is a major repressive target of miR-122, a miR that has a central role in NAFLD and liver cancer. However, little is known about the function of SLC25A34. To investigate SLC25A34 in vitro, mitochondrial respiration and bioenergetics were examined using hepatocytes depleted of Slc25a34 or overexpressing Slc25a34. To test the function of SLC25A34 in vivo, a hepatocyte-specific knockout mouse was generated, and loss of SLC25A34 was assessed in mice maintained on a chow diet and a fast-food diet (FFD), a model for NAFLD. Hepatocytes depleted of Slc25a34 displayed increased mitochondrial biogenesis, lipid synthesis, and ADP/ATP ratio; Slc25a34 overexpression had the opposite effect. In the knockout model on chow diet, SLC25A34 loss modestly affected liver function (altered glucose metabolism was the most pronounced defect). RNA-sequencing revealed changes in metabolic processes, especially fatty acid metabolism. After 2 months on FFD, knockouts had a more severe phenotype, with increased lipid content and impaired glucose tolerance, which was attenuated after longer FFD feeding (6 months). This work thus presents a novel model for studying SLC25A34 in vivo in which SLC25A34 plays a role in mitochondrial respiration and bioenergetics during NAFLD.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35718058      PMCID: PMC9472157          DOI: 10.1016/j.ajpath.2022.06.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   5.770


  62 in total

1.  Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.

Authors:  Shu-Hao Hsu; Bo Wang; Huban Kutay; Hemant Bid; Julia Shreve; Xiaoli Zhang; Stefan Costinean; Anna Bratasz; Peter Houghton; Kalpana Ghoshal
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

2.  Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.

Authors:  Bianca M Arendt; Elena M Comelli; David W L Ma; Wendy Lou; Anastasia Teterina; TaeHyung Kim; Scott K Fung; David K H Wong; Ian McGilvray; Sandra E Fischer; Johane P Allard
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

3.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 4.  Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

Authors:  Detlef Schuppan; Jörn M Schattenberg
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 5.  Mitochondrial biogenesis in neurodegeneration.

Authors:  P Andy Li; Xiaolin Hou; Shaocai Hao
Journal:  J Neurosci Res       Date:  2017-03-16       Impact factor: 4.164

6.  Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice.

Authors:  Sébastien Anthérieu; Dounia Le Guillou; Cédric Coulouarn; Karima Begriche; Viviane Trak-Smayra; Sophie Martinais; Mathieu Porceddu; Marie-Anne Robin; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2014-02-11       Impact factor: 4.219

7.  DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination.

Authors:  Wen Guo; Lan Jiang; Shalender Bhasin; Shaharyar M Khan; Russell H Swerdlow
Journal:  Mitochondrion       Date:  2009-03-24       Impact factor: 4.160

8.  Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Craig D Fisher; Jonathan P Jackson; Rhiannon N Hardwick; D Dean Billheimer; Walter T Klimecki; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-07-07       Impact factor: 3.922

9.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity.

Authors:  Suneng Fu; Ling Yang; Ping Li; Oliver Hofmann; Lee Dicker; Winston Hide; Xihong Lin; Steven M Watkins; Alexander R Ivanov; Gökhan S Hotamisligil
Journal:  Nature       Date:  2011-05-01       Impact factor: 49.962

10.  Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.

Authors:  Lia R Edmunds; Bingxian Xie; Amanda M Mills; Brydie R Huckestein; Ramya Undamatla; Anjana Murali; Martha M Pangburn; James Martin; Ian Sipula; Brett A Kaufman; Iain Scott; Michael J Jurczak
Journal:  Mol Metab       Date:  2020-07-10       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.